Search in:

Expert Opinion on Drug Discovery Volume 16, 2021 - Issue 8

Submit an article Journal homepage

784

Views

CrossRef citations to date

Altmetric

Review

Recent trends in the development of Toll-like receptor 7/8-targeting therapeutics

Xuan Huanga State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaView further author information

Xiaoyong Zhanga State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaView further author information

Mengji Lub Institute of Virology, University Hospital of Essen, Essen, GermanyCorrespondence[email protected]
View further author information

Pages 869-880 | Received 30 Jul 2020, Accepted 01 Mar 2021, Published online: 15 Mar 2021

Cite this article
https://doi.org/10.1080/17460441.2021.1898369
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (14)

Haotian Chen, Yao Zhang, Xingyu Chen, Runshi Xu, Yuxing Zhu, Dong He, YaXin Cheng, Zhanwang Wang, Xiang Qing & Ke Cao. (2023) Hypoxia is correlated with the tumor immune microenvironment: Potential application of immunotherapy in bladder cancer. Cancer Medicine.
Crossref

Hyo-Jin Kim, Hyemin Kim, Jeong-Hyung Lee & Cheol Hwangbo. (2023) Toll-like receptor 4 (TLR4): new insight immune and aging. Immunity & Ageing 20:1.
Crossref

Fang Li, Biao SongWei-Feng ZhouLi-Jin Chu. (2023) Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy. Viral Immunology 36:9, pages 564-578.
Crossref

Irene Veneziani, Claudia Alicata, Lorenzo Moretta & Enrico Maggi. (2023) Human toll-like receptor 8 (TLR8) in NK cells: Implication for cancer immunotherapy. Immunology Letters 261, pages 13-16.
Crossref

Hao Sun, Yingmei Li, Peng Zhang, Haizhou Xing, Song Zhao, Yongping Song, Dingming Wan & Jifeng Yu. (2022) Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives. Biomarker Research 10:1.
Crossref

Liyuan Wang, Guiqiang Zhang, Yang Sun, Zhuanchang Wu, Caiyue Ren, Zhaoying Zhang, Xueqi Peng, Yankun Zhang, Ying Zhao, Chunyang Li, Lifen Gao, Xiaohong Liang, Haifeng Sun, Jiwei Cui & Chunhong Ma. (2022) Enhanced Delivery of TLR7/8 Agonists by Metal–Organic Frameworks for Hepatitis B Virus Cure. ACS Applied Materials & Interfaces 14:41, pages 46176-46187.
Crossref

Xiaoxiao Li, Ling Chen, Xiaobo Peng & Xianbao Zhan. (2022) Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor. Frontiers in Oncology 12.
Crossref

Zhou Tian, Baojian Hong, Jianzhong Chen & Zhe Tang. (2022) Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis. Frontiers in Oncology 12.
Crossref

Junfeng Chu, Fengcai Gao, Meimei Yan, Shuang Zhao, Zheng Yan, Bian Shi & Yanyan Liu. (2022) Natural killer cells: a promising immunotherapy for cancer. Journal of Translational Medicine 20:1.
Crossref

Olaia Akesolo, Berta Buey, Manuel Beltrán-Visiedo, David Giraldos, Isabel Marzo & Eva Latorre. (2022) Toll-like receptors: New targets for multiple myeloma treatment?. Biochemical Pharmacology 199, pages 114992.
Crossref

Claudia Betschart, Michael Faller, Florence Zink, René Hemmig, Jutta Blank, Eric Vangrevelinghe, Marjorie Bourrel, Ralf Glatthar, Dirk Behnke, Kerstin Barker, Andreas Heizmann, Daniela Angst, Pierre Nimsgern, Sébastien Jacquier, Tobias Junt, Géraldine Zipfel, Giulia Ruzzante, Pius Loetscher, Sarah Limonta, Stuart Hawtin, Cedric Bernard Andre, Thomas Boulay, Roland Feifel & Thomas Knoepfel. (2022) Structure-Based Optimization of a Fragment-like TLR8 Binding Screening Hit to an In Vivo Efficacious TLR7/8 Antagonist . ACS Medicinal Chemistry Letters 13:4, pages 658-664.
Crossref

Irene Veneziani, Claudia Alicata, Andrea Pelosi, Nadine Landolina, Biancamaria Ricci, Valentina D'Oria, Anna Fagotti, Giovanni Scambia, Lorenzo Moretta & Enrico Maggi. (2022) Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56 bright CD16 − subset . Journal for ImmunoTherapy of Cancer 10:1, pages e003385.
Crossref

Izabela Szulc-Kielbik & Michal Kielbik. 2022. Interaction of Immune and Cancer Cells. Interaction of Immune and Cancer Cells 107 140 .

Feng-Zhen Meng, Jin-Biao Liu, Xu Wang, Peng Wang, Wen-Hui Hu, Wei Hou & Wen-Zhe Ho. (2021) TLR7 Activation of Macrophages by Imiquimod Inhibits HIV Infection through Modulation of Viral Entry Cellular Factors. Biology 10:7, pages 661.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Recent trends in the development of Toll-like receptor 7/8-targeting therapeutics

Articles from other publishers (14)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Recent trends in the development of Toll-like receptor 7/8-targeting therapeutics

Citations (14)

Articles from other publishers (14)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date